病毒过滤市场 - 全球产业规模、份额、趋势、机会和预测，按产品（消耗品、仪器、服务）、按技术、按最终用途、按地区和竞争进行细分，2020-2030 年

2024 年全球病毒过滤市场价值为 53.1 亿美元，预计到 2030 年将达到 74.1 亿美元，预测期内复合年增长率为 8.67%。在生物製药和疫苗生产领域，确保产品安全至关重要。病毒等污染物会危及这些救命药物的功效和安全性。全球病毒过滤市场已成为维护生物製药完整性和确保患者健康的重要参与者。

病毒过滤是生物製药製造的关键步骤，特别是在疫苗、治疗性蛋白质和单株抗体的生产中。病毒比大多数细菌和其他微生物都要小，因此清除它们是一项艰鉅的任务。如果不加以解决，病毒污染会导致严重的健康风险，使生物製药产品不再适合人类使用。病毒过滤的主要目的是消除生物製药产品中的病毒，同时保留所需分子的完整性。该过程不仅确保了最终产品的安全，而且还满足了监管要求。美国食品药物管理局（FDA）和欧洲药品管理局（EMA）等监管机构制定了严格的指导方针，以确保生物製药的品质和安全，并强调有效的病毒过滤的重要性。

由于生物製药在治疗多种疾病方面具有功效，因此对生物製药的需求正在稳步上升。这种不断增长的需求导致生物製药产量增加，进而推动了对病毒过滤技术的需求。病毒过滤领域的不断研究和开发，导致了更高效、更强大的过滤技术的诞生。这些创新正在提高病毒过滤的效率，使其能够被更广泛的生物製药公司所使用。政府和私人实体正在增加对医疗保健和製药领域的投资，从而刺激生物製药行业和病毒过滤市场的成长。

主要市场驱动因素

生物製药产业蓬勃发展，推动全球病毒过滤市场发展

主要市场挑战

病毒过滤系统和耗材成本高

主要市场趋势

技术进步

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球病毒过滤市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 依产品（消耗品{试剂盒和试剂，其他}，仪器（过滤系统，层析系统），服务）
  • 依技术（过滤、色谱法）
  • 按最终用途划分（生物製药和生物技术公司、合约研究组织、学术机构和研究实验室、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图

第 6 章：北美病毒过滤市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 加拿大
  • 墨西哥

第 7 章：欧洲病毒过滤市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 英国
  • 义大利
  • 法国
  • 西班牙

第 8 章：亚太地区病毒过滤市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 印度
  • 日本
  • 韩国
  • 澳洲

第 9 章：南美洲病毒过滤市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 阿根廷
  • 哥伦比亚

第 10 章：中东和非洲病毒过滤市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 合併与收购（如有）
• 产品发布（如果有）
• 最新动态

第 13 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品的威胁

第 14 章：竞争格局

• Danaher Corporation
• Merck KGaA
• Sartorius AG
• Thermo Fisher Scientific Inc.
• GE Healthcare Technologies, Inc.
• Charles River Laboratories
• Asahi Kasei Medical Co., Ltd.
• WuXi AppTec
• Lonza Group AG
• Clean Biologics

第 15 章：策略建议

第16章 调査会社について・免责事项

Global Virus Filtration Market was valued at USD 5.31 Billion in 2024 and is expected to reach USD 7.41 Billion by 2030 with a CAGR of 8.67% during the forecast period. In the world of biopharmaceuticals and vaccine production, ensuring product safety is paramount. Contaminants such as viruses can jeopardize the efficacy and safety of these life-saving drugs. The global virus filtration market has emerged as a vital player in safeguarding the integrity of biopharmaceuticals and ensuring patient well-being.

Virus filtration is a critical step in biopharmaceutical manufacturing, particularly in the production of vaccines, therapeutic proteins, and monoclonal antibodies. Viruses are smaller than most bacteria and other microorganisms, making their removal a challenging task. Left unaddressed, viral contamination can lead to serious health risks, rendering biopharmaceutical products unsafe for human use. The primary objective of virus filtration is to eliminate viruses from biopharmaceutical products while retaining the desired molecules intact. This process not only ensures the safety of the end product but also satisfies regulatory requirements. Regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have stringent guidelines in place to ensure the quality and safety of biopharmaceuticals, emphasizing the importance of effective virus filtration.

The demand for biopharmaceuticals is steadily rising due to their efficacy in treating a wide range of diseases. This growing demand has led to an increase in biopharmaceutical production, subsequently driving the demand for virus filtration technologies. Continuous research and development in the field of virus filtration have led to the creation of more efficient and robust filtration technologies. These innovations are enhancing the efficacy of virus filtration, making it more accessible to a broader range of biopharmaceutical companies. Governments and private entities are increasing their investments in healthcare and pharmaceuticals, thus stimulating the growth of the biopharmaceutical sector and the virus filtration market.

Key Market Drivers

Growing Biopharmaceutical Industry is Driving the Global Virus Filtration Market

The biopharmaceutical industry is in the midst of a transformative era, marked by innovative research, breakthrough therapies, and an ever-increasing demand for high-quality biologics. This growth is not only revolutionizing the way diseases are treated but is also propelling various associated markets to new heights. One such market that has been on the rise is the global virus filtration market, driven by the continuous expansion and success of the biopharmaceutical sector. The biopharmaceutical industry encompasses a wide range of drugs and therapies, including monoclonal antibodies, vaccines, gene therapies, and other complex biologics. These treatments are designed to address some of the most challenging medical conditions, from cancer and rare diseases to autoimmune disorders and infectious diseases. In September 2022, the U.S.

The world has witnessed the emergence of various infectious diseases, such as COVID-19. These global health crises highlight the importance of virus filtration in vaccine production and diagnostic testing. Consequently, increased R&D efforts are directed toward improving virus filtration methods and technologies. Gene therapy is an evolving field with the potential to revolutionize medical treatments. To meet the stringent safety standards for gene therapy products, R&D activities are dedicated to enhancing virus filtration techniques. Automation in bioprocessing is becoming more prevalent. Advanced virus filtration technologies are needed to keep pace with the automation trend and maintain product quality.

The expanding R&D activities are driving the global virus filtration market in several ways. R&D investments enable the development of cutting-edge virus filtration technologies that are more efficient, cost-effective, and adaptable to various applications. Regulatory authorities are continually raising the bar for product safety and purity. This compels companies to invest in research and development to meet these standards, which often necessitate advanced virus filtration techniques. Collaborations between research institutions, biotech companies, and pharmaceutical giants foster innovation and contribute to the growth of the virus filtration market. The competitive nature of the pharmaceutical and biotechnology industries encourages companies to invest in R&D to gain a competitive edge by offering superior virus filtration solutions.

Expanding research and development activities have become the engine driving the global virus filtration market. As industries such as pharmaceuticals, biotechnology, and life sciences continue to evolve and grow, the demand for reliable and efficient virus filtration solutions will persist. The relentless pursuit of product safety and purity, along with the emergence of new infectious diseases and the rise of biopharmaceuticals and gene therapies, all contribute to the sustained expansion of the virus filtration market. To stay at the forefront of this dynamic industry, companies must continue to invest in R&D and innovation, ensuring that the safety and efficacy of their products remain uncompromised.

Key Market Challenges

High Cost of Virus Filtration Systems and Consumables

One of the major challenges in the Global Virus Filtration Market is the high cost associated with virus filtration systems, consumables, and maintenance. Virus filtration is a critical step in biopharmaceutical manufacturing, ensuring product safety by removing viral contaminants. However, the development and production of virus-retentive membranes, single-use filtration systems, and automated filtration technologies require advanced engineering and rigorous quality control measures, which contribute to their high price. Additionally, the cost of validation studies, including virus clearance testing and integrity checks, adds to the overall expense for biopharmaceutical manufacturers. Small and mid-sized biotech firms, particularly those in emerging markets, often struggle to afford these filtration systems, limiting their ability to comply with stringent regulatory requirements. The high capital investment required for setting up virus filtration infrastructure further restricts its adoption among contract research organizations (CROs) and smaller-scale biopharmaceutical manufacturers. Moreover, consumables such as filter cartridges, membranes, and buffer solutions must be replaced regularly, increasing operational costs. As the demand for biologics, gene therapies, and vaccines grows, cost-effective virus filtration solutions are needed to ensure wider accessibility. Manufacturers are exploring innovative materials, process optimizations, and alternative filtration techniques to reduce costs while maintaining high virus removal efficiency. However, achieving this balance remains a challenge, particularly for new market entrants with limited financial resources.

Key Market Trends

Technological Advancements

The global virus filtration market is experiencing a remarkable surge, largely attributed to the relentless pace of technological advancements. Virus filtration has become an indispensable process in pharmaceuticals, biotechnology, and research industries. It plays a pivotal role in ensuring the safety and purity of biopharmaceutical products and protecting against potential viral contaminants. As the world continues to grapple with infectious diseases and the quest for cutting-edge therapies intensifies, the demand for advanced virus filtration solutions is skyrocketing.

One of the most significant technological advancements in virus filtration is the development of advanced nanofiltration membranes. These highly specialized filters have smaller pore sizes, making them more effective in removing even the smallest of viruses. The use of nanofiltration has become increasingly common in the biopharmaceutical industry. Single-use virus filtration systems have gained prominence due to their cost-effectiveness and convenience. These systems incorporate disposable components that reduce the risk of cross-contamination and alleviate the need for extensive cleaning and validation processes. The advent of viral clearance technology has revolutionized the virus filtration process. It enables the efficient removal of viruses while preserving the integrity of biopharmaceutical products. This technology has improved the overall safety and efficacy of biopharmaceuticals. Improved detection methods, including advanced analytical instruments and real-time monitoring systems, allow for the early identification and tracking of potential viral contaminants. These advancements enable pharmaceutical companies to take prompt action to prevent contamination.

Key Market Players

• Merck KGaA
• Danaher Corporation
• Sartorius AG
• Thermo Fisher Scientific Inc.
• GE Healthcare Technologies, Inc.
• Charles River Laboratories
• Asahi Kasei Medical Co., Ltd.
• WuXi AppTec
• Lonza Group AG
• Clean Biologics

Report Scope:

In this report, the Global Virus Filtration Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Virus Filtration Market, By Product:

• Consumables
• Instruments
• Services

Virus Filtration Market, By Technology:

• Filtration
• Chromatography

Virus Filtration Market, By End use:

• Biopharmaceutical & biotechnology companies
• Contract research organizations
• Academic institutes & research laboratories
• Others

Virus Filtration Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Virus Filtration Market.

Available Customizations:

Global Virus Filtration market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Virus Filtration Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Consumables {Kits and reagents, Others}, Instruments (Filtration systems, Chromatography systems), Services)
  • 5.2.2. By Technology (Filtration, Chromatography)
  • 5.2.3. By End Use (Biopharmaceutical & biotechnology companies, Contract research organizations, Academic institutes & research laboratories, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Virus Filtration Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technology
  • 6.2.3. By End Use
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Virus Filtration Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By End Use
  • 6.3.2. Canada Virus Filtration Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By End Use
  • 6.3.3. Mexico Virus Filtration Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By End Use

7. Europe Virus Filtration Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technology
  • 7.2.3. By End Use
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Virus Filtration Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By End Use
  • 7.3.2. United Kingdom Virus Filtration Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By End Use
  • 7.3.3. Italy Virus Filtration Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By End Use
  • 7.3.4. France Virus Filtration Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By End Use
  • 7.3.5. Spain Virus Filtration Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By End Use

8. Asia-Pacific Virus Filtration Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technology
  • 8.2.3. By End Use
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Virus Filtration Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By End Use
  • 8.3.2. India Virus Filtration Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By End Use
  • 8.3.3. Japan Virus Filtration Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By End Use
  • 8.3.4. South Korea Virus Filtration Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By End Use
  • 8.3.5. Australia Virus Filtration Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By End Use

9. South America Virus Filtration Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technology
  • 9.2.3. By End Use
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Virus Filtration Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By End Use
  • 9.3.2. Argentina Virus Filtration Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By End Use
  • 9.3.3. Colombia Virus Filtration Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By End Use

10. Middle East and Africa Virus Filtration Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technology
  • 10.2.3. By End Use
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Virus Filtration Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By End Use
  • 10.3.2. Saudi Arabia Virus Filtration Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By End Use
  • 10.3.3. UAE Virus Filtration Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By End Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Danaher Corporation
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Merck KGaA
• 14.3. Sartorius AG
• 14.4. Thermo Fisher Scientific Inc.
• 14.5. GE Healthcare Technologies, Inc.
• 14.6. Charles River Laboratories
• 14.7. Asahi Kasei Medical Co., Ltd.
• 14.8. WuXi AppTec
• 14.9. Lonza Group AG
• 14.10. Clean Biologics

15. Strategic Recommendations

16. About Us & Disclaimer